Peptide Synthesis

Nanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.

Nanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.

Nanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.

Nanocs' amino acid and peptide PEG conjugates were made from the covalent attachment of PEG to various amino acid derivatives. Conjugates were provided in lyophilized powder form.

Immunogen 19 amino acids near the amino terminus of human ATP11A. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 19 amino acids near the amino terminus of human ATP2C2. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 15 amino acids near the amino terminus of Avian Influenza A (H5N1) hemagglutinin. Application Used as a blocking peptide in immunoblotting applications.

Store at -20°C. Store under desiccating conditions. The product can be stored for up to 12 months.

Application L-Aspartic acid &#946-benzyl ester is used in the synthesis of peptides with a 1,4-diazepine-2,5-dione ring structure and in development of block copolymers.

Immunogen 14 amino acids near the carboxy terminus of human BAG1. Application Used as a blocking peptide in immunoblotting applications.

Immunogen 19 amino acids near the amino terminus of human BANF1 Application Used as a blocking peptide in immunoblotting applications. Linkage This peptide blocks the action of antibody PRS4019 .

BCN-PEG3-VC-PFP Ester is a cleavable ADC linker. The Val-Cit will specifically be cleaved by Cathepsin B. As this enzyme is only present in the lysosome, the ADC payload will be released only in the cell. The BCN group can react with azide-tagged